drugset / Trial / NCT04298528

A RCT Comparing Dronabinol to a Placebo for Post-operative Pain in Total Joint Arthroplasty

NCT04298528

Phase 3 Unknown 460 enrolled Colorado Joint Replacement
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose of this study was to determine if cannabinoid use decreases narcotic consumption in patients undergoing total knee arthroplasty (TKA).

Timeline

Start
2020-02-05
Primary completion
2024-02-05
Completion
2025-02-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronabinol Other / unclassified 2.5 mg

Indications